ACHL

Achilles Therapeutics PLC Sponsored ADR · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website achillestx.com
Employees(FY) 234
ISIN US00449L1026

Performance

+0.94%

+4.9%

+48.61%

+16.3%

+20.36%

YTD

+28.92%

Profile

Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom.

Advanced Technical Analysis

Technical Analysis of ACHL 2024-12-02

The stock exhibits a strong bullish sentiment with a Moving Average Score of 90, indicating robust upward momentum, while the Technical Score of 71 further supports this positive outlook. However, the Oscillators Score of 53 suggests a more neutral stance, indicating potential consolidation or a pause in the upward trend.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of ACHL

Stock Rank

Recent News & Updates

2024-11-18 18:00
Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market(Globenewswire)
2024-11-13 18:00
Achilles Therapeutics Reports Third Quarter 2024 Financial Results(Globenewswire)
2024-09-22 21:40
Is Achilles Therapeutics (ACHL) Stock Outpacing Its Medical Peers This Year?(Yahoo Finance)
2024-09-18 19:00
Achilles Therapeutics Announces Strategic Update(Globenewswire)
2024-08-13 19:00
Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates(Globenewswire)
2024-05-21 19:00
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines(Globenewswire)
2024-05-17 05:00
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement(Globenewswire)
2024-05-08 01:53
ACHL Stock Earnings: Achilles Therapeutics Beats EPS for Q1 2024(Investorplace)
2024-05-07 19:00
Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights(Globenewswire)
2024-04-03 23:53
ACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023(Investorplace)
2024-04-03 18:45
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights(Globenewswire)
2024-04-03 18:30
Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning(Globenewswire)
2024-02-04 18:00
Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference(Globenewswire)
2023-12-17 18:00
Achilles Therapeutics Announces Publication of Nature Cancer 'Comment' on Strategy for Improved Neoantigen Immunogenicity Prediction(Globenewswire)
2023-11-13 03:30
Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights(Globenewswire)
2023-10-24 00:30
10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis(Yahoo Finance)
2023-09-22 04:30
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement(Yahoo Finance)
2023-09-21 21:40
Are Medical Stocks Lagging Achilles Therapeutics (ACHL) This Year?(Yahoo Finance)
2023-09-13 00:05
Waters (WAT) Walk-Up Solutions Boost Bioprocess Development(Yahoo Finance)
2023-09-05 21:40
Is KalVista Pharmaceuticals (KALV) Stock Outpacing Its Medical Peers This Year?(Yahoo Finance)
2023-08-09 23:50
Jazz (JAZZ) Beats on Q2 Earnings & Sales, Raises '23 View(Yahoo Finance)
2023-08-03 19:00
Achilles Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights(Yahoo Finance)
2023-06-11 20:00
Achilles Therapeutics to Present at Upcoming Conferences(Yahoo Finance)
2023-05-20 22:03
3 Stocks With 1,000% Upside Potential(Yahoo Finance)
2023-05-09 19:15
Achilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights(Yahoo Finance)
2023-05-09 19:00
Achilles Therapeutics New Immunogenicity Prediction Application of its AI-Powered PELEUS Platform Uniquely Identifies the Most Potent T Cell Antigens(Yahoo Finance)
2023-04-25 06:00
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement(Yahoo Finance)
2023-04-24 19:00
Achilles Therapeutics Announces Grant of US Patent Covering the Treatment of Patients with an Immunotherapy Targeting Neoantigens Based on Tumor HLA Status(Yahoo Finance)
2023-04-21 21:45
Is Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Deliver On Growth Plans?(Yahoo Finance)
2023-04-16 20:00
Achilles Therapeutics to Present at Chardans 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit(Yahoo Finance)

Page 1 of 4

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.